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Abstract  
 
Objective. To investigate the independent effects of pregnancy planning and smoking 
during pregnancy on neonatal outcome.   
Design.  Population-based cohort study. 
Setting. UK Millennium Cohort Study. 
Sample. 18,178 singleton babies born in UK between 2000 and 2001.  
Methods. Logistic regression was used to estimate the association between pregnancy 
planning and/or smoking and neonatal outcome. Adjusted odds ratios were used to 
calculate population attributable risk fractions(PAFs). 
Main Outcome measures. Low birthweight (<2.5Kg) and pre-term birth (<37 completed 
weeks gestation).  
Results.  43% of mothers did not plan their pregnancy and 34% were smoking just before 
and/or during pregnancy.  Planners were half as likely to be smokers just before pregnancy, 
and more likely to give up or reduce the amount smoked if smokers. Unplanned pregnancies 
had 24% increased odds of low birth weight and prematurity compared to planned 
pregnancies (AORLBW1.24, 95%CI1.04-1.48; AORPREM1.24, 95%CI1.05-1.45), independent of 
smoking status.  The odds of low birth weight for babies of mothers who were smoking just 
before pregnancy was 91% higher than that of mothers who were not (AORLBW1.91, 
95%CI1.56-2.34).  Women who quit or reduced the amount smoked during pregnancy 
lowered the risk of low birth weight by one third (AORLBW0.66, 95% CI0.51-0.85) compared 
with women whose smoking level did not change. Smaller effects were found for 
prematurity. If all women planned their pregnancy and did not smoke before or during 
pregnancy, 30% of low birthweight and 14% of prematurity could, in theory, be avoided.  
Conclusions. Planning a pregnancy and avoiding smoking during pregnancy has clear, 
independent, health benefits for babies.  Quitting or reducing the amount smoked during 
pregnancy can reduce the risk of low birthweight.  
Keywords. Pregnancy planning, smoking, low birthweight, prematurity.
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Background   
Pre-pregnancy health and care is an important factor in improving the health of the future 
generations.  Growing evidence about the 'fetal origins of adult disease'[1] and from the 
field of epigenetics [2] indicate the large potential benefits of preconception and inter-
conception care for both women and men.  The life course approach to disease highlights 
the importance of the intrauterine environment in preventing future disease and the 
preconception period is seen as a critical period where intervention can lead to long term 
benefit. [3] The National Health Service (NHS) offers a range of guidance to women hoping 
to become pregnant. [4] Avoiding behaviour that can be detrimental to health, such as 
smoking during pregnancy, are highlighted in the NHS’s guidance. This is because smoking in 
pregnancy has a clear adverse impact on neonatal outcome, including preterm delivery, low 
birth weight, [5,6,7] still birth and up to 40% increased risk of infant mortality.[8]  The 
National Institute for Health and Care Excellence (NICE) [9] offers public health guidance to 
health professionals for interventions to help women and partners to quit smoking including 
carbon monoxide testing and referral to smoking cessation services.  
The NHS guidance also gives advice on how long it is expected for a woman to become 
pregnant and what options there are for fertility treatment if there are difficulties in 
becoming pregnant. [4] But there is no information on the health impact of pregnancy 
planning itself, reflecting the fact that there has been little research on decisions made by a 
woman before pregnancy and how that affects health related behaviours and  the health of 
the child. Such information is important if interventions to improve neonatal outcome by 
preparing for pregnancy are to be initiated, and these interventions may need to be 
targeted towards particular groups who are less likely to plan for pregnancy.  
This study uses Millennium cohort data to examine the independent effects of pregnancy 
planning and smoking during pregnancy on neonatal outcome. Specific objectives were to (i) 
examine the association between planning and smoking status, and (ii) examine the 
independent effects of pregnancy planning and smoking status on neonatal outcome, and 
(iii) estimate the proportion of adverse neonatal outcome that could be avoided in the 
population if all mothers planned their pregnancies and / or avoided smoking in pregnancy. 
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Methods 
The Millennium Cohort Study 
The MCS is a nationally representative cohort study conducted by the Centre for 
Longitudinal Studies at the Institute of Education, London (http://www.cls.ioe.ac.uk/), that 
follows the lives of over 18,819 babies born throughout Great Britain and Northern Ireland 
between 2000 and 2001.[10a&b] The MCS first collected information on the babies and 
their families from their two main carers (most commonly their mother and father) when 
the babies were around nine months old. The MCS attained an overall response rate of 68% 
throughout the whole of the UK.[10a&b]  As part of the survey design the MCS oversampled 
in areas with high child poverty and in England also in areas with increased prevalence of 
ethnic minority populations. [10b]  
Pregnancy planning and smoking in pregnancy   
The two main exposure variables were pregnancy planning and smoking status, which were 
asked about at the first interview when the child was 9 months of age. Pregnancy planning 
information came from the question to the mother “Were you planning to get pregnant or 
was it a surprise?”. Women were grouped into those who planned, and those who did not 
plan, the pregnancy. Smoking status during pregnancy came from questions about current 
and past smoking, including the question “How many cigarettes a day were you usually 
smoking just before you became pregnant?” and “Did you change the amount you smoked 
during your pregnancy?”. All women who reported a change had a reduction in the amount 
smoked.  Women were classified as smokers just before pregnancy if they reported 1 or 
more cigarettes per day.  For the analysis, four categories of smoking status during 
pregnancy were: (i) never-smoker; (ii) ex-smoker (given up before pregnancy); (iii) smoker 
just before pregnancy and had either quit smoking or had reduced the amount smoked 
during pregnancy; and (iv) smoker just before pregnancy and continued to smoke the same 
amount during pregnancy (no change).  
Neonatal outcome 
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The outcome variables were low birthweight (less than 2.5Kg or 2.5Kg and above) and pre-
term birth (<37 completed weeks or 37 or more completed weeks gestation).  
Study population 
This analysis investigated singleton births only. Records of babies from multiple births and 
corresponding carer information were dropped from the analysis (n=522). A further 18 
records were dropped from the analysis because the respondents were not immediate 
family members.  100 records had missing information on pregnancy planning, and 816 
records had missing smoking information, leaving a total of 18,178 records with planning 
information and 17,462 records with smoking information.  Further records (less than 145) 
with missing data on socio-economic characteristics and neonatal outcome were dropped 
from analyses, as appropriate: the numbers in each analysis are presented in the tables.   
Statistical analysis 
Data for this analysis were taken from the first sweep only, accessed through the Economic 
and Social Data Service (http://www.esds.ac.uk/). All analyses used the statistical software 
package STATA, version 11. The survey design, oversampling and response rate were 
accounted for using the svyset command (and subsequent svy commands) in STATA using 
specific countrywide variables that had already been created.   
Socio-demographic characteristics and the health status of women who planned, and did 
not plan, the index pregnancy were compared using descriptive tabulations and Chi square 
tests.  Similar comparisons were made for women in the four smoking groups.   
Univariable logistic regression was used to investigate the association between pregnancy 
planning, or smoking status, and neonatal outcome. Multivariable analysis was then 
conducted, including confounding variables in the model if they were associated with the 
outcome at a 5% level after adjustment for other factors in the model. Effect modification 
between planning and smoking status was investigated using Likelihood Ratio Tests 
(ignoring the SVY command). If no interaction was detected (p>0.05) further adjustment 
was made for smoking status or planning, as appropriate.  
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Adjusted population attributable risk fractions (PAFs) were used to assess the independent 
impact of pregnancy planning and smoking on low birthweight and preterm delivery in this 
population. PAFs were computed using for formula: 
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PAF (%) =    p (AOR -1)       x  100 
    P (AOR -1) + 1 
 
Where:  p = proportion of population who did not plan their pregnancies/ or who 
smoked around the time of pregnancy, and  AOR= Adjusted odds ratio  
 
PAFs to estimate  the joint impact of pregnancy planning and smoking were calculated  
using the method described in   Bruzzi et all, 1985.  [11]  
Results 
Characteristics of the study population by planning and smoking status 
Overall, 57% (10,405/18,178) of mothers of singleton births reported that they planned the 
pregnancy (Appendix S1).  Compared to planners, non-planners were younger and left 
school at an earlier age, were more likely to be classified as deprived, and less likely to be 
married and to have White ethnicity. The babies who were not planned were of higher birth 
order than babies who were planned and there was some indication that mothers who 
reported not planning their pregnancy were more likely to be underweight before 
pregnancy than women who did plan (Appendix S1). 
Fifty four percent (9,370/17,462) of mothers had never smoked and 12% (n=2,071) were ex-
smokers. Thirty four percent were smokers just before the pregnancy and, of these, 81% 
quit or decreased the amount they smoked during the course of the pregnancy (Appendix 
S2).   Compared to the non-smokers, smokers were younger and left school at an earlier 
age, were more likely to be classified as deprived, and less likely to be married. Again, there 
was some evidence that mothers who smoked around the time of the pregnancy were more 
likely to be underweight before pregnancy than women who did not smoke. Babies of 
mothers who continued to smoke in pregnancy had higher birth order than babies born to 
mothers in the other three smoking groups (Appendix S2).  
Association between smoking and planning a pregnancy 
There was a clear association between planning a pregnancy and not smoking just before 
pregnancy (p<0.001, Table 1). Of the planners, 62% were never smokers, 12% ex-smokers 
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and 26% were smoking just before pregnancy.  The corresponding figures for mothers who 
did not plan their pregnancy were 46% never-smokers, 7% ex-smokers and 47% smoking 
just before pregnancy.  Of those smoking just before pregnancy, 84% of the planners and 
77% of the non-planners either quit smoking or reduced the amount they smoked in 
pregnancy (Table 1).  
 
 
Association between pregnancy planning, smoking in pregnancy, and neonatal outcome 
Overall, 6% (1,102/18,178) of babies in the study population were born with low 
birthweight and 7% (n=1,279) were born preterm.  
Pregnancy planning 
The proportion of low birthweight babies was lower for mothers who planned their 
pregnancy (5.2%) than for mothers who did not plan (7.2%).  After adjusting for socio-
demographic confounding factors (see table footnotes for details of adjustment factors) 
there was a statistically significant 27% increased odds of low birthweight for the children of 
mothers who did not plan compared to those who did (AOR 1.27, 95% CI 1.06-1.51)(Table 
2).  No effect modification between pregnancy planning and smoking was detected (p>0.05). 
After further adjustment for smoking status, effect of planning reduced slightly to 24% 
increased odds (AOR 1.24, 95% CI 1.04-1.48), remaining statistically significant. Similarly, 
6.3% of children whose mothers planned their pregnancy were born prematurely, compared 
to 8.2% of children whose mothers did not, with adjusted odds ratios showing 24% 
increased odds of prematurity associated with non-planning (AOR 1.24, 95% CI 1.05-1.45).   
Smoking 
The proportion of babies with low birthweight was higher for mothers who smoked just 
before pregnancy (8.3%) than for those who did not (5.0%).  After adjustment for socio-
demographic factors (see table footnotes for details) and pregnancy planning (no effect 
modification between smoking and pregnancy planning detected, p>0.05), there was a 
statistically significant 91% increased odds of low birthweight associated with smoking 
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before pregnancy (AOR 1.91, 95% CI 1.56-2.34)(Table 3).  A smaller effect was seen for 
prematurity, the adjusted odds ratio showing 12% increased odds associated with smoking 
(AOR 1.12, 95% CI 0.95-1.35). 
Further analysis of neonatal outcome for the children of mothers who reported smoking just 
before pregnancy showed that those mothers who quit or decreased the amount smoked 
during pregnancy had a lower proportion of low birthweight babies (7.6%) compared to 
mothers who continued to smoke the same amount in pregnancy (11.5%). After adjustment 
for confounding factors, including pregnancy planning, the odds of low birthweight for 
babies born to mothers who changed their smoking habits during pregnancy were reduced 
by 34% (AOR 0.66, 95% CI 0.51-0.85) (table 4).  A smaller and non-statistically significant 
effect of quitting or decreasing the amount smoked during pregnancy was seen for 
prematurity (AOR 0.85, 95% CI 0.67-1.09).   
Population Attributable risk Fractions 
Figure 1 presents the hypothetical proportion of adverse outcome that could be avoided if 
we assume that all women in this population planned their pregnancies, or no women 
smoked around the time of pregnancy, or both.  Over 20% of low birthweight, and 4% of 
prematurity could have been avoided if no women smoked during and/or just before 
pregnancy.  For pregnancy planning, the potential saving was a further 10% of both low 
birthweight and prematurity. The combined savings if all women planned and no women 
smoked, was almost 30% of low birthweight and 14% of prematurity.   
Discussion   
Main findings 
Not surprisingly, those women who planned their pregnancy were less likely to smoke than 
those for whom the pregnancy was a surprise.  However, there was strong evidence for an 
association between planning a pregnancy and neonatal outcome which was independent 
of smoking status.  Surprise pregnancies had almost one quarter increased risk of low birth 
weight and prematurity compared to pregnancies which were planned after allowing for 
differences in smoking. Smoking just before pregnancy had a stronger association with low 
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birthweight, smokers having over 90% increased risk of low birthweight compared to non-
smokers.  For those who were smoking just before pregnancy, giving up or reducing the 
amount smoked had a clear beneficial effect on low birthweight, risks being reduced by just 
over one third. These effects were independent of planning status and other health 
behaviours measured in this cohort..  We estimated that, in theory, 30% of low birthweight, 
and 14% of premature births, could have been avoided in this population if all women 
planned their pregnancies and were non-smokers around the time of pregnancy.  
 
Strengths and Limitations  
This analysis used data from a large, nationally representative, UK cohort study.  The size 
provided the study with good statistical power and the data contained information on 
potential confounding factors with a low proportion of missing information.  However, as 
the information was collected nine months post birth there is likely to be some information 
bias as respondents were asked to recall events up to two years before they were 
interviewed.  Self-reported smoking habits, in particular, is vulnerable to underreporting 
[12]. Although we are reassured to some extent that the rates of pre-pregnancy smoking 
were similar to national rates for 2000 reported elsewhere [13], we need to assess the 
impact of underreporting of smoking during pregnancy on our findings.  If underreporting of 
smoking during pregnancy was similar in those with, and without, a low birthweight or 
preterm baby the effect would be to bias the measure of effect towards a null effect.  It is 
thus unlikely to be an explanation for the smoking effects seen in these data. However, 
since the outcome of pregnancy was known at the time the questions on smoking were 
asked, we have to consider the possibility that underreporting of smoking status during 
pregnancy could be different for those with, and without, a low birthweight/preterm baby.   
For differential under-reporting of smoking habits to explain the findings reported here, 
under-reporting would have to be less likely (reporting being more accurate) for mothers 
with low birthweight/preterm babies compared to that for mothers with babies not low 
birthweight/preterm.  We have no way of checking this with available data, and differential 
under-reporting of smoking during pregnancy may explain some of the effects reported 
here.  
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The MCS also only obtained information on babies that had survived to roughly nine 
months. A subsequent investigation estimated that 180 babies did not survive to nine 
months of age and so were not able to be surveyed. [14]  Four percent of records also had 
missing smoking data.  Since death and smoking are related to lowbirthweight and 
prematurity, missing data of this type may have resulted in an underestimation of the effect 
of smoking on lowbirthweight and smoking in this analysis.   
Part of this research compared smokers who changed their behaviour and those who did 
not. There may have been some women in the no change group who continued to smoke a 
relatively little amount, and those in the group that changed their smoking behaviour who 
still smoked a comparatively large amount, for example if they cut down from 40 cigarettes 
per day to 10.  We did not examine amounts smoked in this analysis. However, such 
misclassification of exposure would tend to bias the measure of effect towards the null, 
making our findings conservative rather than inflated.  
Interpretation 
The characteristics of women in the MCS who planned, or did not plan, their pregnancies, 
and who smoked, or not, just before pregnancy has been reported before.[15,16]  As 
expected, we found similar socio-economic distributions for these sub-groups within the 
MCS population. However, what is unique in the current - analysis is examination of the 
relationship between planning and smoking, and their independent effects on neonatal 
outcome.   
While it may seem intuitive that unplanned pregnancies would be associated with poorer 
neonatal outcomes, the literature on this question is not extensive and is somewhat 
conflicting. One of the main reasons for this is the issue of adjustment for confounding 
factors including a range of health-seeking behaviours that may be associated with 
pregnancy planning but independently related to birth outcomes, such as good antenatal 
care.  
Studies of women who plan compared to those who do not have investigated the effect on 
health related behaviours such as smoking, alcohol consumption, folic acid supplementation 
and antenatal care attendance. A study of Turkish - pregnant women interviewed in an 
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antenatal setting found that 71% planned their pregnancy and they were less likely to 
smoke, have lower alcohol consumption, go to more antenatal sessions and take more 
supplementation and nutrition compared to those who did not plan.[17] The effect of 
planning a pregnancy appeared beneficial in this study, but a Swedish study found only 20% 
of women planning their pregnancy took folic acid during the period in which they were 
planning. [18] A Canadian study found a similar level of 28% of women who planned took 
folic acid supplementation.[19] In both the latter two studies, folic acid supplementation 
was more common in those who planned, compared to those who did not plan, their 
pregnancy, but the percentage falls far short of optimum coverage of folic acid 
supplementation before and during pregnancy. 
Green-Raleigh et al found that women who were planning to get pregnant were more likely 
to decrease their consumption, or abstain, from alcohol. [20] The study also found that 
women planning to get pregnant were less likely to be smokers,[20]  as we found in the 
current study. Another study which looked at the effect of planning in adolescents, found 
that those who planned their pregnancies had a higher rate of smoking, STDs, leaving school 
and subsequent pregnancies compared to those who did not plan.[21] It is thus unclear 
whether the positive effect of planning on health behaviour transcends across different age 
groups or if such decisions may affect subsequent changes in health related behaviour.  
There has been surprisingly little research into the effect of pregnancy planning on 
morbidity in pregnancy but unplanned pregnancy, severe pregnancy related nausea and 
vomiting, high perceived stress and low social support were found to be associated with 
lower levels of psycho-social adjustment during pregnancy in a Taiwanese study.[22] A study 
in Turkey also found women who did not plan their pregnancies had higher rates of 
depressive symptoms during their pregnancy.[23]  
Research from as early as the 1970s showed that smoking in pregnancy increases the risk of 
having a low birth weight baby.[24] Our findings add to this evidence-base, demonstrating a 
clear impact of smoking on low birthweight after adjustment for confounding factors. 
Smoking during pregnancy has also been shown to increase the risk of having a baby that is 
small for gestational age and suffering from fetal growth restriction. [25,26,27] The impact 
on the fetus’ growth may be partly explained by the increased incidence of abnormal 
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placental structure and function related to smoking.[28] A review of intervention studies 
has also shown that smoking cessation during pregnancy can reduce the risk of low birth 
weight and pre-term birth.[29]  
Conclusions  
Evidence about the adverse effect of smoking before and during pregnancy is strong, and 
effective smoking cessation interventions have been identified.  Our study provides 
additional evidence of the benefits of stopping or reducing smoking during pregnancy.  The 
message that it is never too late to give up smoking needs to be emphasised, especially at 
this critical time and for disadvantaged women who are more likely to smoke during 
pregnancy.  
With over 40% of pregnancies in this study being a surprise, a more targeted policy to 
increase pregnancy planning and awareness of pre-pregnancy health is recommended. 
Compared to pregnancy planners, non-planners tended to be young, single and less well 
educated women. However, more rigorous measurement of pregnancy planning is needed 
to establish the full impact of pregnancy planning on neonatal outcomes.  
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Table 2: Association between pregnancy planning status and neonatal outcome 
 
Neonatal outcome 
in mothers who 
planned pregnancy 
 
Neonatal outcome 
in mothers who did 
not plan pregnancy 
 
Crude 1 
Adjusted  
Model 1 * 
Adjusted  
Model 2 ** 
n/N (%) n/N (%) OR 95% CI OR 95% CI OR 95% CI 
Low Birth 
weight(<2.5kg) 
541/10,394 (5.21) 561/7,762(7.22) 1.42 1.22-1.65 1.27 1.06-1.51 1.24 1.04-1.48 
Prematurity 
(< 37 weeks 
gestation) 
653/10,359 (6.30) 626/7,675 (8.16) 1.32  1.15-1.52 1.23 1.05-1.45 1.24 1.05-1.45 
¹ The baseline group was women who had planned their pregnancy  
*All adjusted for: mother’s age, deprivation, relationship status, fertility treatment. Prematurity also adjusted for BMI.  
** Adjusted for the same variables as model 1 plus smoking.  
 
Table 1: Association between pregnancy planning status and smoking status 
 
Smoking status just before pregnancy 
Total 
 
 
n  
(%) 
 
Never Smoked 
 
n  
 (%)  
 
Ex-smoker 
 
n  
 (%) 
Smoker: 
Decreased or Quit 
in Pregnancy 
n  
(%) 
[within smoker %] 
Smoker : 
No Change in 
Pregnancy 
n  
(%) 
[within smoker %] 
Mothers who 
planned 
pregnancy 
5,870 
(62.3) 
1,173 
(12.4) 
1,955 
(21.1) 
[82.1] 
425 
(4.5) 
[17.9] 
9,463 
(100) 
[100] 
Mothers who 
did not plan 
pregnancy 
3,674 
(45.9) 
574 
(7.2) 
2,902 
(36.2) 
[77.1] 
860 
(10.7) 
[22.9] 
8,010 
(100) 
[100] 
Chi square for heterogeneity p<0.001  
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Table 4: Association between change in smoking behaviour during pregnancy (yes/no) and 
neonatal outcome,  in mothers who smoked just before pregnancy 
 
Mothers who smoked just before 
pregnancy 
Crude ¹ Adjusted 1* Adjusted 2** 
Neonatal outcome in 
mothers who did not 
change their 
smoking habit during 
pregnancy 
Neonatal outcome 
in mothers who 
decreased or quit 
smoking during 
pregnancy 
n/N (%) n/N (%) OR 95% CI OR 95% CI OR 95% CI 
Low Birth 
weight(<2.5kg) 
136/1,183(11.50) 365/4,834(7.55) 
0.62 0.50-0.79 0.65 0.50-0.84 0.66 0.51-0.85 
Prematurity 
(< 37 weeks 
gestation) 
109/1,167 (9.34) 376/4,799 (7.83) 
0.82 0.65-1.03 0.85 0.67-1.08 0.85 0.67-1.09 
¹ Baseline group was women who did not change their smoking habit during pregnancy 
*Birth weight adjusted for mother’s age, education, ethnicity, religion and BMI. Prematurity adjusted for mother’s age, relationship 
status and education.   
** Adjusted for the same variables as model 1 plus planning. 
 
 
 
 
Table 3: Association between smoking before pregnancy (yes/no) and neonatal outcome 
 
Neonatal outcome in 
mothers who did not 
smoke before or 
during their 
pregnancy 
Neonatal outcome 
in mothers who 
smoked* 
before pregnancy 
 
Crude1 Adjusted 1 ** Adjusted 2*** 
n/N (%) n/N (%) OR 95% CI OR 95% CI OR 95% CI 
Low Birth 
weight(<2.5kg) 
569/11,429 (5.00) 501/6,017 (8.33) 
1.73 1.42-2.05 1.98 1.62-2.41 1.91 1.56-2.34 
Prematurity 
(< 37 weeks 
gestation) 
748/11,352 (6.59) 485/5,966 (8.13) 
1.25 1.09-1.45 1.14 0.96-1.35 1.12 0.95-1.35 
¹ The baseline group was women who did not smoke during pregnancy  
*Including women who reduced or quit smoking at some time during pregnancy 
**All adjusted for mother’s age and mothers education.  Birth weight is also adjusted for ethnicity, religion and BMI. Prematurity also 
adjusted for relationship status.  
*** Adjusted for the same variables as model 1 plus planning.  
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